arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

FITLIFE BRANDS, INC.

FTLF
$10.12 ▲ +0.14 (+1.40%) at close
Materials ·Medicinal Chemicals & Botanical Products ·USMedicinal Chemicals & Botanical Products
66 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
71
Health
Good
Bullish
auto_awesome

Analytical Summary

FITLIFE BRANDS, INC. shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $95.0M
Dividend Yield
Revenue Growth 58.9%
Op. Margin 12.1%
ROIC 4.9%
FCF / Share $0.26
Trailing P/E 56.2x
Price / Book 2.1x
FCF Yield 2.6%
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

66-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$25.32M
↑ +58.9%
Net Income Profit after all expenses
$1.72M
↓ -14.8%
Operating Margin Operating profit as % of sales
12.1%
↑ +22.5% 62th
FCF / Share Free cash flow per share
$0.26
↑ +5.8%
Long-Term Debt Long-term obligations
$46.46M
↑ +635.0%
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
60
Returns
79
Financial Health
75
Cash Quality
72

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 17 years · 66 quarters